Quarterly report · Q3
4528.TEDINET S100SO43
Period2023-04-01 → 2023-12-31
Filed2024-02-06
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥389.9bn | 2023-04-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥131.2bn | 2023-10-01 → 2023-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥447.2bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥339.0bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥122.3bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥144.6bn | 2023-04-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥47.6bn | 2023-10-01 → 2023-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥122.6bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥42.3bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥147.3bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥48.0bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥143.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥124.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥43.4bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥110.5bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥36.1bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥95.7bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥33.3bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥110.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥36.1bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥95.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥33.4bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥891.7bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥882.4bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥830.5bn | at 2022-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥101.0bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥134.6bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥790.7bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥747.8bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥727.3bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥661.7bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥784.7bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥741.9bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥721.4bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥102.2bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥96.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥108.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥69.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥61.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥159.6bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥115.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | ¥19.4bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥100.3bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥44.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥75.4bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥32.5bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥30.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥229.08 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥75.77 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥230.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥195.9 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥68.23 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥229.06 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥75.76 | 2023-10-01 → 2023-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥230.79 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥195.88 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥68.22 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 88.0% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 84.1% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 86.9% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 573
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sale of investments inv cf IFRS | CurrentYTDDuration | 2820000000 | JPY |
| Payments into time deposits inv cf IFRS | Prior1YTDDuration | -52975000000 | JPY |
| Payments into time deposits inv cf IFRS | CurrentYTDDuration | -33009000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf IFRS | Prior1YTDDuration | 12811000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf IFRS | CurrentYTDDuration | 63009000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | -400000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | -1092000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -44852000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | 19373000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -28800000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -36152000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -6000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -9000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -2065000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -1946000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -1000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYTDDuration | -37251000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -30872000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -75358000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1YTDDuration | 39340000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | CurrentYTDDuration | 5513000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 69112000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 96135000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 141000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 599000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 108593000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 102247000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-02-06 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第76期第３四半期(自 2023年10月１日 至 2023年12月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)小野薬品工業株式会社 | |
| Company name in english cover page | FilingDateInstant | ONO PHARMACEUTICAL CO., LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 相 良 暁 | |
| Address of registered headquarter cover page | FilingDateInstant | Text · Plus | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当事項はありません。 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪市中央区久太郎町一丁目８番２号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪(06)6263局5670番 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経営管理統括部長 伊 藤 雅 樹 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00945 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45280 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)小野薬品工業株式会社 | |
| Filer name in english | FilingDateInstant | ONO PHARMACEUTICAL CO., LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |